Search Lavipharm.com

 

Peania, April 15th, 2020 – 21 tons of LAVISEPT at the National Healthcare System
Supporting PEF’s initiative for free production of antiseptic products

Peania, April 15th, 2020 – 21 tons of LAVISEPT at the National Healthcare System
Supporting PEF’s initiative for free production of antiseptic products

Peania, April 15th, 2020 – Lavipharm, responding to the call of the state and society and in collaboration with the Ministry of Health, the Independent Public Revenue Authority (AADE) and the Panhellenic Association of the Pharmaceutical Industry (PEF), participates in the production and free distribution of antiseptic solutions in order to meet immediate needs of the healthcare system.

“Our main objective”, commented Dr. Athanase Lavidas, Executive Chairman of Lavipharm, “is the safety and protection of people in the first line of duty, called to face effectively the increased demand for patients’ medical care. Nowadays, society needs our real support, by all means, to reinforce our healthcare system. We have to stand by all healthcare professionals who are facing daily, restless and courageously, unprecedented situations. At this critical time, the Greek pharmaceutical industry is called to be at the forefront of armoring public health”.

By actively contributing to the fight against the spread of coronavirus, Lavipharm received about 20 tons of ethyl alcohol by the Ministry of Health and produces at the company’s facilities in Peania appx 50.000 LAVISEPT antiseptic gel, in bottles of 500ml, to be  distributed by the state wherever is needed the most.

“In this extremely critical time”, highlighted Mr. Panayiotis Giannouleas, Chief Operating Officer & Country Manager of Lavipharm, “continuing our work in the production and supply chain of pharmaceutical and antiseptic products is above all our duty and a tangible proof of our solidarity. The Lavipharm family is on the ramparts of this collective effort and is responding thanks to the coordinated and admirable effort of all our people”.

Lavipharm is an integrated Group of Companies engaged in the research, development, manufacturing, imports, marketing and sales, wholesaling, and retailing of pharmaceutical, dermocosmetic and healthcare products in Greece with a strong international activity.